Loading the player...

PANEL: New Diagnostic Screening Tools and Predictive Analytics – Oncology and Beyond

Next-gen sequencing has driven much of the biomarker and diagnostic activity in oncology and immuno-oncology, but predictive biomarkers and tools are making an impact in other areas. What are some of the lessons learned from the use of diagnostics in treating cancer and what other areas are poised for impact? Which technologies are driving the development of these new diagnostics and predictive tools and their clinical adoption? We heard from company executives working on both clinical and consumer applications who will be sharing their product demos.

Speakers : Taylor Sittler, Justin Kao, Sonia Sousa, Heather Bowerman, Sean Bell, Linda Molnar
Companies : ColorGenomics, Helix, Kenzen, DotLab, Arivale,